• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Caym. Inds·Basic Materials·4148.TW
Share

All Cosmos Bio-Tech Holding Corporation Stocks

NT$ 29.9Last Updated 09.07.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

NT$ 64.88M

NT$ 29.9
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

All Cosmos Bio-Tech Holding Corporation, through its various operating units, primarily focuses on the production and distribution of bio-organic and bio-chemical compound fertilizers across Malaysia. The company also dedicates efforts to the research and development of microorganisms, particularly for the sustainable management of oil palm waste. Furthermore, it engages in the bulk supply of probiotics. Its activities extend to forest management and associated research initiatives. Internationally, All Cosmos Bio-Tech exports its various offerings to markets including Taiwan, Indonesia, Vietnam, and China. The corporation was established in 1999 and maintains its head office in George Town, Cayman Islands.

Company Valuation

Undervalued
6/7

Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, undervalued on EV/EBITDA, underpriced on P

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

11.07.2026 19:01

A Triumph for City Governments? How China’s Scaling Model Will Change the Global AI Market

11.07.2026 16:01

Highlights from Small-Caps: Royce Fund Forecast, Trump's Sons' Investments, the Chewy Case Study

11.07.2026 15:32

SK Hynix's Record-Breaking IPO: What's Behind the Hype Surrounding Memory Chip Manufacturers

11.07.2026 13:01

Where Holann Is Investing, AI to Focus on Pharmaceuticals, and SK Hynix's Record-Breaking Offering

11.07.2026 12:20

Freedom Holding Raised $300 Million for International Expansion

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026